To provide a Tau-binding antibody or a binding fragment thereof for treating or diagnosing tauopathies such as Alzheimer's disease (AD) or progressive supranuclear palsy (PSP).SOLUTION: A Tau-binding antibody or a binding fragment thereof has characteristics such as capability of binding to both soluble forms and paired helical filaments (PHFs) of human Tau.SELECTED DRAWING: None
TAU-BINDING ANTIBODIES